CARE Ratings Q4 FY26 Preview: Revenue Growth Expectations and Earnings Outlook

Tue Mar 17 2026

CARE Ratings Q4 FY26 results date is all set to be announced soon and most investors are awaiting it. Professionals are expecting an increase in revenue due to higher sales and a significant rise in PAT. CARE Ratings was listed on the National Stock Exchange (NSE) on 26-Dec-2012. CARE Ratings share has its face value of 10 per share, and its NSE symbol is CARERATING. The company operates in the Financial Services sector and primarily belongs to the Credit Rating Agency industry.

Table of Contents

CARE Ratings Q4 Results 2026 Preview

CARE Ratings Q4 FY26 revenue is expected to be around Moderate Growth, representing a 11% YoY increase compared to the same quarter last year.
Profit After Tax, or PAT, is projected to rise 12% YoY.
EBITDA to rise 11%.
CARE Ratings is expected to show Moderate Growth in its revenue.

Click and Sign Up to Get Live Updates on Q4 Results

CARE Ratings Share Performance

Over the past six months, CARE Ratings share price has positive by 8% to 1,554.20.
Moreover, over the past year, the stock has positive by 18%
Despite this weak short-term performance, CARE Ratings stock has delivered a financially sound 134% return over the past 5 years.
As of today, 13-03-2026, the CARE Ratings share price is trading at 1,554.20 per share.

Key Factors to Watch for CARE Ratings Q4 Results FY26

Revenue Growth & Segment Performance – Focus on topline growth in the Credit Rating Agency industry within the Financial Services sector.
Occupancy Levels & Seat Expansion – Monitor operational expansion and capacity utilisation trends.
Profitability & Margin Trends – Track EBITDA and PAT margins to evaluate cost control and operating efficiency.
Order Book & New Client Wins – Watch for updates on new contracts, partnerships, and long-term deals.
Balance Sheet & Cash Flow Position – Review debt levels, working capital management, and operating cash flows for financial stability.

About CARE Ratings

CARE Ratings is a credit rating agency providing ratings and research services across corporate, financial, and infrastructure sectors. The company benefits from growth in bond markets and structured finance activity.

Download the Univest iOS App or Univest Android App to get daily stock recommendations and insightful research pieces!

Final Thoughts

CARE Ratings is gear up to announce its Q4 FY26 results. Analysts expect 11% revenue growth, a 12% rise in PAT, and a 11% rise in EBITDA. CARE Ratings focuses on revenue growth from order execution, margin improvement, a strong order book, and management.

Stay informed with Univest blogs to get real-time updates on CARE Ratings Q4 results FY26.

Disclaimer: Investment in the share market is subject to risk. This news article is for informational purposes only. Conduct your own research before investing in shares and other securities.